Bio-waiver of Sapro­pterin dihydrochloride powder for oral solution [Dissolution / BCS / IVIVC]

posted by AB661 – India, 2019-11-22 17:49 (798 d 20:06 ago) – Posting: # 20861
Views: 3,239

Dear All,

We are developing Sapropterin dihydrochloride powder for oral solution,

We are going to file BCS based Bio-waiver approach using solubility, dissolution & composition similarity.

But for permeability study there is no literature support for human absolute bioavailability study or in-vitro permeability study of Sapropterin dihydrochloride. Whether USFDA accept our proposal without permeability study data ?

With regards

Edit: Category changed; see also this post #1[Helmut]

Complete thread:

 Admin contact
21,858 posts in 4,574 threads, 1,554 registered users;
online 17 (0 registered, 17 guests [including 13 identified bots]).
Forum time: Saturday 13:56 CET (Europe/Vienna)

Truth in science can be defined as the working hypothesis best suited
to open the way to the next better one.    Konrad Lorenz

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz